A study led by CHP/PCOR trainee Kaleb D. Michaud has found that drugs known as anti-TNF inhibitors decrease the risk of death among patients with rheumatoid arthritis, while the drug prednisone increases mortality risks.
Recently published research led by CHP/PCOR's %people1% finds that for patients with blocked coronary arteries, bypass surgery is more cost-effective, and results in a better quality of life, than angioplasty including the use of stents. The research is covered in the Oct. 22 issue of weekly trade publication Biotech Week, by the online news service Science Daily, and was referenced in an Oct. 3 segment that aired on WBBM-TV (Chicago).
Obesity is a well-documented problem in developed countries, and Stanford Health Policy researchers have conducted a series of studies on the topic—including one observing its impact on America’s lower-income workers and another study assessing parental effects on childhood obesity in the United States.
CHP/PCOR trainee Eran Bendavid was an author in a piece released in the May issue of the journal Medical Care. The study found that hospitals that operate at or over capacity may be at an increased risk of adverse events that injure patients.